GB0222516D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0222516D0 GB0222516D0 GB0222516A GB0222516A GB0222516D0 GB 0222516 D0 GB0222516 D0 GB 0222516D0 GB 0222516 A GB0222516 A GB 0222516A GB 0222516 A GB0222516 A GB 0222516A GB 0222516 D0 GB0222516 D0 GB 0222516D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0222516A GB0222516D0 (en) | 2002-09-27 | 2002-09-27 | Novel compounds |
PCT/EP2003/010108 WO2004037792A2 (en) | 2002-09-27 | 2003-09-10 | Benzo (f) quinolinone variants as nuclear hormone receptor ligands |
AU2003293305A AU2003293305A1 (en) | 2002-09-27 | 2003-09-10 | Benzo (f) quinolinone variants as nuclear hormone receptor ligands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0222516A GB0222516D0 (en) | 2002-09-27 | 2002-09-27 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0222516D0 true GB0222516D0 (en) | 2002-11-06 |
Family
ID=9944918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0222516A Ceased GB0222516D0 (en) | 2002-09-27 | 2002-09-27 | Novel compounds |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003293305A1 (en) |
GB (1) | GB0222516D0 (en) |
WO (1) | WO2004037792A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
TWI492943B (en) | 2008-12-05 | 2015-07-21 | 大塚製藥股份有限公司 | Quinolone compound and pharmaceutical composition |
BR112015008515A2 (en) | 2012-10-16 | 2017-07-04 | Janssen Pharmaceutica Nv | heteroaryl-linked quinolinyl ror t modulators |
WO2014062667A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of ror-gamma-t |
UY35084A (en) | 2012-10-16 | 2014-04-30 | Janssen Pharmaceutica Nv | MODULATORS OF RORYT OF QUINOLINILO UNITED BY METHYLENE |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
EP3083561B1 (en) * | 2013-10-15 | 2018-12-05 | Janssen Pharmaceutica NV | Heteroaryl linked quinolinyl modulators of roryt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
EP3057422B1 (en) | 2013-10-15 | 2019-05-15 | Janssen Pharmaceutica NV | Quinolinyl modulators of ror(gamma)t |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
US9346782B2 (en) | 2013-10-15 | 2016-05-24 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
CN109721536B (en) * | 2017-10-27 | 2020-11-24 | 广东东阳光药业有限公司 | Phenyl-substituted fused tricyclic compounds and their uses |
CN108218770A (en) * | 2018-02-28 | 2018-06-29 | 南京波普生物医药研发有限公司 | The preparation method of the chloro- 7,8- dihydros -6H- quinoline -5- ketone of 2- |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0102046A1 (en) * | 1982-08-26 | 1984-03-07 | Schering Corporation | Tricyclic lactams, method for making them, pharmaceutical compositions containing them |
US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
US5693646A (en) * | 1994-12-22 | 1997-12-02 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
US5629007A (en) * | 1995-03-21 | 1997-05-13 | Eli Lilly And Company | Method of preventing prostatic cancer development |
US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
-
2002
- 2002-09-27 GB GB0222516A patent/GB0222516D0/en not_active Ceased
-
2003
- 2003-09-10 WO PCT/EP2003/010108 patent/WO2004037792A2/en not_active Application Discontinuation
- 2003-09-10 AU AU2003293305A patent/AU2003293305A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004037792A2 (en) | 2004-05-06 |
AU2003293305A1 (en) | 2004-05-13 |
AU2003293305A8 (en) | 2004-05-13 |
WO2004037792A3 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0202216D0 (en) | Novel compounds | |
GB0205256D0 (en) | Novel compounds | |
GB0202679D0 (en) | Novel compounds | |
GB0206723D0 (en) | Novel compounds | |
GB0222516D0 (en) | Novel compounds | |
GB0207249D0 (en) | Novel compounds | |
GB0207246D0 (en) | Novel compounds | |
GB0203299D0 (en) | Novel compounds | |
GB0200025D0 (en) | Novel compounds | |
GB0204252D0 (en) | Novel compounds | |
GB0229822D0 (en) | Novel compounds | |
GB0202636D0 (en) | Novel compounds | |
GB0204305D0 (en) | Novel compounds | |
GB0203902D0 (en) | Novel compounds | |
GB0203680D0 (en) | Novel compounds | |
GB0207283D0 (en) | Novel compounds | |
GB0203677D0 (en) | Novel compounds | |
GB0207281D0 (en) | Novel compounds | |
GB0207278D0 (en) | Novel compounds | |
GB0207275D0 (en) | Novel compounds | |
GB0203673D0 (en) | Novel compounds | |
GB0203437D0 (en) | Novel compounds | |
GB0203369D0 (en) | Novel compounds | |
GB0202637D0 (en) | Novel compounds | |
GB0200108D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |